Novartis AG ADR

NYS: NVS

GO
/marketstate/country/us

Countdown to close

NVS
/zigman2/quotes/203243705/composite

$

97.98

Change

+1.08 +1.12%

Volume

Volume 2.55m

Jan 25, 2021, 3:11 p.m.

Real time quotes

/zigman2/quotes/203243705/composite

Previous close

$ 96.90

$ 97.98

Change

+1.08 +1.12%

Day low

Day high

$96.74

$98.34

Open
Open: 97.19

52 week low

52 week high

$69.18

$99.84

Open

Market cap

$213.98B

Average volume

1.88M

P/E ratio

31.58

Rev. per Employee

$457,559

EPS

3.11

Dividend

3.09

Div yield

2.04%

Ex dividend date

3/3/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nvs

MarketWatch News on NVS

  1. Best Income Investments for 2021

    12:41 p.m. Jan. 4, 2021

    - Barron's Online

  2. Novartis to buy Cadent for up to $770 million

    2:21 a.m. Dec. 17, 2020

    - MarketWatch.com

  3. Novartis's Beovu meets Phase-3 primary endpoint

    1:54 a.m. Dec. 15, 2020

    - MarketWatch.com

  4. Novartis COVID-19 treatment doesn't meet endpoints

    1:45 a.m. Dec. 14, 2020

    - MarketWatch.com

  5. Novartis to repurchase up to $2.5 billion shares

    1:55 a.m. Nov. 24, 2020

    - MarketWatch.com

  6. Novartis CAN-Covid trial doesn't meet endpoints

    1:59 a.m. Nov. 6, 2020

    - MarketWatch.com

  7. Novartis Phase 4 migraine study meets endpoints

    2:32 a.m. Nov. 2, 2020

    - MarketWatch.com

  8. Novartis profit falls, lifts core op. income view

    1:55 a.m. Oct. 27, 2020

    - MarketWatch.com

  9. Bayer Is Betting on Gene Therapy With a $4 Billion U.S. Acquisition

    10:37 a.m. Oct. 26, 2020

    - Barron's Online

  10. Why Snap’s Surge Is Good News for Social Media

    8:30 p.m. Oct. 23, 2020

    - Barron's Online

  11. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/nvs

Other News on NVS

  1. Novartis Q4 2020 Earnings Preview

    1:33 p.m. Today

    - Seeking Alpha

  2. GlaxoSmithKline: 30% Undervalued And Spinoff To Drive Growth

    11:27 p.m. Jan. 24, 2021

    - Seeking Alpha

  3. Sana Biotechnology Seeks $150 Million U.S. IPO

    1:54 p.m. Jan. 22, 2021

    - Seeking Alpha

  4. Regional Banks Post Mixed Earnings Results

    10:54 a.m. Jan. 22, 2021

    - Zacks.com

  5. Q4 Earnings Come to Regional Banks: ALLY, HBAN & More

    10:27 a.m. Jan. 22, 2021

    - Zacks.com

  6. Healthcare: Thoughts For The New Year

    7:57 p.m. Jan. 21, 2021

    - Seeking Alpha

  7. Merck's (MRK) Heart Failure Drug Vericiguat Gets FDA Nod

    10:29 a.m. Jan. 21, 2021

    - Zacks.com

  8. Top Stock Reports for Novartis, QUALCOMM & Accenture

    12:15 p.m. Jan. 20, 2021

    - Zacks.com

  9. Veeva: Not Enough Risk In This Winning SaaS Platform

    10:15 a.m. Jan. 14, 2021

    - Seeking Alpha

  10. Loading more headlines...
/news/pressrelease/company/us/nvs

Press Releases on NVS

  1. Kinase Inhibitors Market Size is Estimated to Reach USD 63.9 Bn by 2027

    8 min ago

    - Market Insight Reports

  2. Finasteride Market Size : Technological Advancement and Growth Analysis with Forecast to 2026

    9:38 a.m. Today

    - Market Insight Reports

  3. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.